Park et al., 2007 - Google Patents
Association analysis of CD40 polymorphisms with asthma and the level of serum total IgEPark et al., 2007
View PDF- Document ID
- 8165987381438299324
- Author
- Park J
- Chang H
- Park C
- Jang A
- Park B
- Rhim T
- Uh S
- Kim Y
- Chung I
- Shin H
- Publication year
- Publication venue
- American journal of respiratory and critical care medicine
External Links
Snippet
Rationale: The CD40 protein plays important roles in cell-mediated and humoral immune responses, especially in immunoglobulin class-switching to IgE. Objectives: We tested the association of CD40 polymorphisms with the risk of asthma and the level of serum IgE and …
- 102100013137 CD40 0 title abstract description 129
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Park et al. | Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE | |
| Raby et al. | Association of vitamin D receptor gene polymorphisms with childhood and adult asthma | |
| Duetsch et al. | STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study | |
| Poon et al. | Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy | |
| Joos et al. | Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers | |
| Sherrill et al. | Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis | |
| Kruse et al. | Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis | |
| Choi et al. | A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children | |
| Shai et al. | Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families | |
| Paradowska‐Gorycka et al. | Association between IL‐17F gene polymorphisms and susceptibility to and severity of Rheumatoid Arthritis (RA) | |
| Tajouri et al. | Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population | |
| Yao et al. | Genome-wide association study of lung function phenotypes in a founder population | |
| Eilertsen et al. | Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case–control study | |
| Sayers et al. | Promoter polymorphism in the 5‐lipoxygenase (ALOX5) and 5‐lipoxygenase‐activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population | |
| Gao et al. | Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population | |
| Namkung et al. | IL‐5 and IL‐5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans | |
| Akkad et al. | Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients | |
| Connolly et al. | Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing | |
| Shin et al. | Association of interleukin 18 (IL18) polymorphisms with specific IgE levels to mite allergens among asthmatic patients | |
| Sasaki et al. | Identification of a novel type 1 diabetes susceptibility gene, T-bet | |
| Hennig et al. | Influence of IL‐10RA and IL‐22 polymorphisms on outcome of hepatitis C virus infection | |
| He et al. | Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers | |
| Wei et al. | Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis | |
| Breunis et al. | Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease | |
| Kim et al. | A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population |